These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 31296552)

  • 21. Cannabis effects on driving lateral control with and without alcohol.
    Hartman RL; Brown TL; Milavetz G; Spurgin A; Pierce RS; Gorelick DA; Gaffney G; Huestis MA
    Drug Alcohol Depend; 2015 Sep; 154():25-37. PubMed ID: 26144593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Passive cannabis smoke exposure and oral fluid testing. II. Two studies of extreme cannabis smoke exposure in a motor vehicle.
    Niedbala RS; Kardos KW; Fritch DF; Kunsman KP; Blum KA; Newland GA; Waga J; Kurtz L; Bronsgeest M; Cone EJ
    J Anal Toxicol; 2005 Oct; 29(7):607-15. PubMed ID: 16419389
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detectability of various cannabinoids in plasma samples of cannabis users: Indicators of recent cannabis use?
    Kraemer M; Madea B; Hess C
    Drug Test Anal; 2019 Oct; 11(10):1498-1506. PubMed ID: 31407526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blood cannabinoid molar metabolite ratios are superior to blood THC as an indicator of recent cannabis smoking.
    Kosnett MJ; Ma M; Dooley G; Wang GS; Friedman K; Brown T; Henthorn TK; Brooks-Russell A
    Clin Toxicol (Phila); 2023 May; 61(5):355-362. PubMed ID: 37293900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantification of cannabinoids and their free and glucuronide metabolites in whole blood by disposable pipette extraction and liquid chromatography-tandem mass spectrometry.
    Scheidweiler KB; Newmeyer MN; Barnes AJ; Huestis MA
    J Chromatogr A; 2016 Jul; 1453():34-42. PubMed ID: 27236483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison between self-report of cannabis use and toxicological detection of THC/THCCOOH in blood and THC in oral fluid in drivers in a roadside survey.
    Van der Linden T; Silverans P; Verstraete AG
    Drug Test Anal; 2014; 6(1-2):137-42. PubMed ID: 23939912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. THC in breath aerosols collected with an impaction filter device before and after legal-market product inhalation-a pilot study.
    Jeerage KM; Beuning CN; Friss AJ; Bidwell LC; Lovestead TM
    J Breath Res; 2023 May; 17(3):. PubMed ID: 37211879
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral fluid and plasma cannabinoid ratios after around-the-clock controlled oral Δ(9)-tetrahydrocannabinol administration.
    Milman G; Schwope DM; Schwilke EW; Darwin WD; Kelly DL; Goodwin RS; Gorelick DA; Huestis MA
    Clin Chem; 2011 Nov; 57(11):1597-606. PubMed ID: 21875944
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Temporal indication of marijuana use can be estimated from plasma and urine concentrations of delta9-tetrahydrocannabinol, 11-hydroxy-delta9-tetrahydrocannabinol, and 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid.
    Manno JE; Manno BR; Kemp PM; Alford DD; Abukhalaf IK; McWilliams ME; Hagaman FN; Fitzgerald MJ
    J Anal Toxicol; 2001 Oct; 25(7):538-49. PubMed ID: 11599597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential physiological and behavioral cues observed in individuals smoking botanical marijuana versus synthetic cannabinoid drugs.
    Chase PB; Hawkins J; Mosier J; Jimenez E; Boesen K; Logan BK; Walter FG
    Clin Toxicol (Phila); 2016; 54(1):14-9. PubMed ID: 26653952
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determination of Δ9-tetrahydrocannabinolic acid A (Δ9-THCA-A) in whole blood and plasma by LC-MS/MS and application in authentic samples from drivers suspected of driving under the influence of cannabis.
    Raikos N; Schmid H; Nussbaumer S; Ambach L; Lanz S; Längin A; König S; Roth N; Auwärter V; Weinmann W
    Forensic Sci Int; 2014 Oct; 243():130-6. PubMed ID: 25173986
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Controlled Cannabis Vaporizer Administration: Blood and Plasma Cannabinoids with and without Alcohol.
    Hartman RL; Brown TL; Milavetz G; Spurgin A; Gorelick DA; Gaffney G; Huestis MA
    Clin Chem; 2015 Jun; 61(6):850-69. PubMed ID: 26019183
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral fluid cannabinoids in chronic, daily Cannabis smokers during sustained, monitored abstinence.
    Lee D; Milman G; Barnes AJ; Goodwin RS; Hirvonen J; Huestis MA
    Clin Chem; 2011 Aug; 57(8):1127-36. PubMed ID: 21677094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Indeterminacy of cannabis impairment and ∆
    Wurz GT; DeGregorio MW
    Sci Rep; 2022 May; 12(1):8323. PubMed ID: 35585089
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blood cannabinoids. II. Models for the prediction of time of marijuana exposure from plasma concentrations of delta 9-tetrahydrocannabinol (THC) and 11-nor-9-carboxy-delta 9-tetrahydrocannabinol (THCCOOH).
    Huestis MA; Henningfield JE; Cone EJ
    J Anal Toxicol; 1992; 16(5):283-90. PubMed ID: 1338216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Do Delta9-tetrahydrocannabinol concentrations indicate recent use in chronic cannabis users?
    Karschner EL; Schwilke EW; Lowe RH; Darwin WD; Pope HG; Herning R; Cadet JL; Huestis MA
    Addiction; 2009 Dec; 104(12):2041-8. PubMed ID: 19804462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Delta9-tetrahydrocannabivarin testing may not have the sensitivity to detect marijuana use among individuals ingesting dronabinol.
    Levin FR; Mariani JJ; Brooks DJ; Xie S; Murray KA
    Drug Alcohol Depend; 2010 Jan; 106(1):65-8. PubMed ID: 19733018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cannabis effects on driving longitudinal control with and without alcohol.
    Hartman RL; Brown TL; Milavetz G; Spurgin A; Pierce RS; Gorelick DA; Gaffney G; Huestis MA
    J Appl Toxicol; 2016 Nov; 36(11):1418-29. PubMed ID: 26889769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimization of recombinant β-glucuronidase hydrolysis and quantification of eight urinary cannabinoids and metabolites by liquid chromatography tandem mass spectrometry.
    Sempio C; Scheidweiler KB; Barnes AJ; Huestis MA
    Drug Test Anal; 2018 Mar; 10(3):518-529. PubMed ID: 28815938
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biomarkers of Recent Cannabis Use in Blood, Oral Fluid and Breath.
    Hubbard JA; Hoffman MA; Ellis SE; Sobolesky PM; Smith BE; Suhandynata RT; Sones EG; Sanford SK; Umlauf A; Huestis MA; Grelotti DJ; Grant I; Marcotte TD; Fitzgerald RL
    J Anal Toxicol; 2021 Sep; 45(8):820-828. PubMed ID: 34185831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.